A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA

被引:65
|
作者
Tassone, F
Hagerman, RJ
Taylor, AK
Hagerman, PJ
机构
[1] Univ Calif Davis, Sch Med, Dept Biol Chem, Davis, CA 95616 USA
[2] Univ Calif Davis, Sch Med, MIND Inst, Davis, CA 95616 USA
[3] Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA
[4] Kimball Genet Inc, Denver, CO USA
关键词
trinucleotide repeat; gene silencing; quantitative RT-PCR; neurodevelopment;
D O I
10.1136/jmg.38.7.453
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
FMR1 mRNA levels were determined in peripheral blood leucocytes for 48 fragile X males with methylated, full mutation alleles that are resistant to cleavage by methylation sensitive enzymes. Using quantitative (fluorescence) RT-PCR, we observed that more than half of these males produce FMR1 mRNA, with some mRNA levels approaching those found in normal subjects. In none of the samples analysed was there any evidence of premutation alleles. These results suggest that the assumed relationship between enzyme resistance and FMR1 gene silencing may not be generally valid. Despite the presence of FMR1 mRNA in some subjects, no FMRP production was detected by either immunocytochemistry or western blotting. The low/absent FMRP levels are probably a reflection of a post-trancriptional effect such as a defect in translation.
引用
收藏
页码:453 / 456
页数:4
相关论文
共 50 条
  • [31] A Novel FMR1 PCR Method for the Routine Detection of Low Abundance Expanded Alleles and Full Mutations in Fragile X Syndrome
    Filipovic-Sadic, Stela
    Sah, Sachin
    Chen, Liangjing
    Krosting, Julie
    Sekinger, Edward
    Zhang, Wenting
    Hagerman, Paul J.
    Stenzel, Timothy T.
    Hadd, Andrew G.
    Latham, Gary J.
    Tassone, Flora
    CLINICAL CHEMISTRY, 2010, 56 (03) : 399 - 408
  • [32] Methylation analysis of the promoter region in fragile X males with hypermethylated, full mutation alleles
    Tassone, F
    Sahota, P
    Pleasant, N
    Laird, C
    Hagerman, P
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 331 - 331
  • [33] A Set of Assays for the Comprehensive Analysis of FMR1 Alleles in the Fragile X-Related Disorders
    Hayward, Bruce E.
    Zhou, Yifan
    Kumari, Daman
    Usdin, Karen
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (05): : 762 - 774
  • [34] High performing male with fragile X syndrome with an unmethylated FMR1 full mutation: The relevance of clinical and genetic correlations
    Shieh, Meg
    Amkraut, Keren
    Spiridigliozzi, Gail A. A.
    Adayev, Tatyana
    Nicholson, Kaylea
    McConkie-Rosell, Allyn
    McDonald, Marie
    Pennington, Malinda
    Sebastian, Siby
    Lachiewicz, Ave M. M.
    CLINICAL CASE REPORTS, 2023, 11 (06):
  • [35] Fragile X-associated tremor/ataxia phenotype in a male carrier of unmethylated full mutation in the FMR1 gene
    Loesch, D. Z.
    Sherwell, S.
    Kinsella, G.
    Tassone, F.
    Taylor, A.
    Amor, D.
    Sung, S.
    Evans, A.
    CLINICAL GENETICS, 2012, 82 (01) : 88 - 92
  • [36] Apparent FMR1 allele instability in non-Fragile X males -: Invited commentary
    Brown, WT
    Nolin, SL
    GENETIC TESTING, 2000, 4 (03): : 241 - 242
  • [37] Autistic Behavior, FMR1 Protein, and Developmental Trajectories in Young Males with Fragile X Syndrome
    Bailey Jr. D.B.
    Hatton D.D.
    Skinner M.
    Mesibov G.
    Journal of Autism and Developmental Disorders, 2001, 31 (2) : 165 - 174
  • [38] Autistic behavior, FMR1 protein, and developmental trajectories in young males with fragile X syndrome
    Bailey, DB
    Hatton, DD
    Skinner, M
    Mesibov, G
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2001, 31 (02) : 165 - 174
  • [39] Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening
    Handt, Maximilian
    Epplen, Andrea
    Hoffjan, Sabine
    Mese, Kemal
    Epplen, Joerg T.
    Dekomien, Gabriele
    MOLECULAR AND CELLULAR PROBES, 2014, 28 (5-6) : 279 - 283
  • [40] Point mutation in intron 10 of FMR1 is unlikely to be a cause of fragile X syndrome
    Vincent, JB
    Gurling, HMD
    HUMAN MUTATION, 1998, 12 (06) : 431 - 431